Sunshine Biopharma CEO Receives Zero‑Cost 100,000‑Share Award Amid Stock Slump: Insider Confidence Sparks Investor Buzz
Sunshine Biopharma’s zero‑cost 100k‑share award from owner Natan David signals insider confidence amid a falling stock, raising hopes for future clinical wins.
3 minutes to read
